Press Release
Global Dry Eye Syndrome Market is Estimated to Reach $4.5 Billion by 2024, Says Variant Market Research
 Published Date:  Oct 2017  Publish By: Variant Market Research

Global Dry Eye Syndrome Market Report, published by Variant Market Research, forecast that the global market is expected to reach $4.9 Billion by 2024 from $2.9Billion in 2016, growing at a CAGR of 6.9% from 2016 to 2024. Dry eye syndrome, is an ocular syndrome, which generally occurs when any living person/animal is unable to produce sufficient tears of their own. It is medically known as dysfunctional tear syndrome. The major reasons of this syndrome are Vitamin A deficiency, LASIK surgery, pregnancy, neurotrophic deficiency and Meibomian gland dysfunction. There are two major categories of this syndrome such as aqueous and evaporative deficiency. Early cure of this disease may save the life of affected person/animal. It is one of the most prevailing diseases globally. It is chronic disorder introduced by advanced age, contact lens wear, certain medications, or environmental reasons.

"Global Dry Eye Syndrome Market (By Type: Evaporative Dry Eye, Aqueous Dry Eye; By Treatment Type: Nutritional Supplements, Serum Eye Drops, Lubricant Eye Drops, Anti-Inflammatory Drugs; and By Geography: North America, Europe, Asia-Pacific and Row)) Opportunities, Growth and Forecast, 2015 - 2024"

To browse the complete report, visit at: https://www.variantmarketresearch.com/report-categories/pharmaceuticals/dry-eye-syndrome-market

Increase in prevalence of dry eye syndrome drives the market

The global dry eye syndrome market is primarily driven by increase in occurrence of dry eye syndrome, rising geriatric population, and increasing awareness about this syndrome. Additionally government initiative for this syndrome and increased R&D are also major dry eye syndrome market trend. Though, expiry of patents on major drugs used in the treatment is a major hindrance for the dry eye syndrome market growth. Moreover, technological advancement and steady government support for medical research is expected to deliver numerous growth opportunities for the market in the upcoming years.

Market Segmentation

The global dry eye syndrome market is majorly classified on the basis of type, treatment type, and geography. By type the market is categorized into evaporative dry eye & aqueous dry eye. On the basis of treatment type the market is further divided into serum eye drops, nutritional supplement, lubricant eye drops (ointments, oily tear eye drops, and preservative-free drops) and anti-inflammatory drugs (Corticosteroids and Tetracyclines). By geography, North America, Europe, Asia-Pacific, and Rest of the World (RoW) are the major segments considered in the dry eye syndrome market.

Aqueous dry eye accounted for the largest market share in the type segment

Aqueous dry eye accounted for the largest market share in 2016, and are expected to continue its dominance during the forecast period 2016 – 2024, in type segment.

Global Dry Eye Syndrome Market, by Treatment Type
Global Dry Eye Syndrome Market Report, published by Variant Market Research, forecast that the global market is expected to reach $4.9 Billion by 2024 from $2.9Billion in 2016, growing at a CAGR of 6.9% from 2016 to 2024.

Nutritional Supplements held the highest market share in the treatment type segment

Nutritional supplements accounted for the largest market share in 2016, and expected to remain the largest over the forecast period 2016 – 2024. .Whereas, lubricant eye drops sub segment is anticipated to grow at a fastest CAGR from 2016 to 2024.

GLOBAL DRY EYE SYNDROME MARKET SHARE BY GEOGRAPHY, 2016 (%)
Global Dry Eye Syndrome Market Report, published by Variant Market Research, forecast that the global market is expected to reach $4.9 Billion by 2024 from $2.9Billion in 2016, growing at a CAGR of 6.9% from 2016 to 2024.

North America to dominate the largest market share over the forecast period

North America accounted for the largest dry eye syndrome market share, due to factors such as growing number of patients with this syndrome, advanced healthcare infrastructure, increasing numerous diseases for example diabetes, lupus, rheumatoid arthritis, scleroderma, and Sjogren's syndrome among others. This growth in North America will definitely influence in the global dye eye syndrome size.

Competitive Landscape

Eyegate Pharma and Valeant pharmaceuticals enter into licensing agreement for egp-437 combination product in post-operative inflammation and pain in ocular surgery patients. Prominent players in global market profiled are Allergan, Alcon, Eyegate Pharma, Otsuka Holdings, Santen Pharmaceutical, Bridge Pharma Inc., LTT Bio-Pharma, Can-Fite Biopharma, Shire/SAR code Bioscience, and Novartis among others.

Contact Us:
John Dave,
Head - Sales
Variant Market Research
649 Mission St, 5th Floor, San Francisco,
CA 94105,United States.
Tel: +1-415-680-2785
Fax: +1-415-680-2786
Email: john.dave@variantmarketresearch.com
Email: help@variantmarketresearch.com


GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Global Dry Eye Syndrome Market by Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Evaporative Dry Eye
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
    4.3 Aqueous Dry Eye
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
Chapter 5 Global Dry Eye Syndrome Market by Treatment Type: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 Nutritional Supplements
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
    5.3 Serum Eye Drops
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
    5.4 Lubricant Eye Drops
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
          5.4.3 Oily Tear Eye Drops
                   5.4.3.1 Market Size and Forecast
          5.4.4 Ointments
                   5.4.4.1 Market Size and Forecast
          5.4.5 Preservative-Free Drops
                   5.4.5.1 Market Size and Forecast
    5.5 Anti-Inflammatory Drugs
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
          5.5.3 Tetracyclines
                   5.5.3.1 Market Size and Forecast
          5.5.4 Corticosteroids
                   5.5.4.1 Market Size and Forecast
Chapter 6 Global Dry Eye Syndrome Market by Geography: Market Size and Forecast, 2015 – 2024
    6.1 Overview
    6.2 North America
          6.2.1 Current Trend and Analysis
          6.2.2 Market Size and Forecast
          6.2.3 U.S.
                   6.2.3.1 Market Size and Forecast
          6.2.4 Canada
                   6.2.4.1 Market Size and Forecast
          6.2.5 Mexico
                   6.2.5.1 Market Size and Forecast
    6.3 Europe
          6.3.1 Current Trend and Analysis
          6.3.2 Market Size and Forecast
          6.3.3 Germany
                   6.3.3.1 Market Size and Forecast
          6.3.4 Italy
                   6.3.4.1 Market Size and Forecast
          6.3.5 United Kingdom
                   6.3.5.1 Market Size and Forecast
          6.3.6 France
                   6.3.6.1 Market Size and Forecast
          6.3.7 Russia
                   6.3.7.1 Market Size and Forecast
          6.3.8 Others
                   6.3.8.1 Market Size and Forecast
    6.4 Asia-Pacific
          6.4.1 Current Trend and Analysis
          6.4.2 Market Size and Forecast
          6.4.3 China
                   6.4.3.1 Market Size and Forecast
          6.4.4 India
                   6.4.4.1 Market Size and Forecast
          6.4.5 Japan
                   6.4.5.1 Market Size and Forecast
          6.4.6 South Korea
                   6.4.6.1 Market Size and Forecast
          6.4.7 Others
                   6.4.7.1 Market Size and Forecast
    6.5 RoW
          6.5.1 Current Trend and Analysis
          6.5.2 Market Size and Forecast
          6.5.3 Middle East
                   6.5.3.1 Market Size and Forecast
          6.5.4 South America
                   6.5.4.1 Market Size and Forecast
          6.5.5 Africa
                   6.5.5.1 Market Size and Forecast
Chapter 7 Company Profiles
    7.1 Allergan
    7.2 Alcon
    7.3 Eyegate Pharma
    7.4 Otsuka Holdings
    7.5 Santen Pharmaceuticals
    7.6 Bridge Pharma Inc.
    7.7 LLT Bio-Pharma
    7.8 Can-Fite Biopharma
    7.9 Shire/SAR Code Bioscience
    7.10 Novartis

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha